BioHarvest Sciences Inc.
BHST
$5.65
$0.030.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.19M | 22.43M | 19.13M | 15.85M | 12.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.19M | 22.43M | 19.13M | 15.85M | 12.67M |
| Cost of Revenue | 11.25M | 10.32M | 9.29M | 8.01M | 7.04M |
| Gross Profit | 13.94M | 12.11M | 9.84M | 7.84M | 5.63M |
| SG&A Expenses | 16.13M | 15.51M | 13.53M | 12.91M | 12.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.18M | 30.28M | 26.89M | 24.71M | 22.64M |
| Operating Income | -6.99M | -7.85M | -7.76M | -8.86M | -9.97M |
| Income Before Tax | -12.91M | -17.19M | -16.23M | -18.39M | -12.56M |
| Income Tax Expenses | 8.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.91 | -17.19 | -16.23 | -18.39 | -12.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.91M | -17.19M | -16.23M | -18.39M | -12.56M |
| EBIT | -6.99M | -7.85M | -7.76M | -8.86M | -9.97M |
| EBITDA | -5.97M | -6.84M | -6.88M | -8.13M | -9.24M |
| EPS Basic | -0.85 | -1.19 | -1.16 | -1.34 | -0.91 |
| Normalized Basic EPS | -0.53 | -0.74 | -0.73 | -0.83 | -0.57 |
| EPS Diluted | -0.85 | -1.19 | -1.16 | -1.34 | -0.91 |
| Normalized Diluted EPS | -0.53 | -0.74 | -0.73 | -0.83 | -0.57 |
| Average Basic Shares Outstanding | 64.77M | 61.48M | 57.56M | 54.63M | 54.19M |
| Average Diluted Shares Outstanding | 64.77M | 61.48M | 57.56M | 54.63M | 54.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |